Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

827
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
827
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

926
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
926
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

631
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
631
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

3.0K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
3.0K
Tissue Transplantation01:24

Tissue Transplantation

1.4K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.4K
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

414
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
414

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Depression in dialysis patients with end-stage kidney disease: investigating the role of psychosocial stressors, co-occurring medical conditions and demographic influences.

BJPsych open·2026
Same author

The Fast-Track Program: A new Organizational Model to Enhance Living Donor and Pre-emptive Kidney Transplantation.

Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia·2026
Same author

Survey of Herpes Zoster in Kidney Transplant Patients: A Single-Center Study.

International journal of urology : official journal of the Japanese Urological Association·2026
Same author

Collapsing Focal Segmental Glomerulosclerosis With Anti-nephrin Antibody Following Minimal Change Disease Possibly Triggered by COVID-19 Infection: A Case Report.

Cureus·2025
Same author

Change in bladder capacity and prognostic predictors of post-transplant vesicoureteral reflux in pediatric kidney transplant recipients: a single-center retrospective cohort study.

Pediatric nephrology (Berlin, Germany)·2025
Same author

Artesunate alleviates kidney fibrosis by restoring klotho protein and suppressing Wnt/β-catenin signalling pathway.

Frontiers in cell and developmental biology·2025

Related Experiment Video

Updated: May 1, 2026

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach
09:15

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach

Published on: May 7, 2019

15.8K

ABO incompatible renal transplants: Good or bad?

Masaki Muramatsu1, Hector Daniel Gonzalez1, Roberto Cacciola1

  • 1Masaki Muramatsu, Magdi M Yaqoob, Carmelo Puliatti, Department of Translational Medicine and Therapeutics, William Harvey Research Institute, Queen Mary University of London, London EC1M 6BQ, United Kingdom.

World Journal of Transplantation
|March 27, 2014
PubMed
Summary

ABO incompatible kidney transplantation (ABOi-KT) now offers outcomes comparable to ABO compatible KT, expanding donor options for end-stage kidney disease patients. While risks and costs exist, evolving protocols simplify ABOi-KT, making it a viable future option.

Keywords:
ABO incompatibleAntibody depletionDesensitization protocolsImmunosuppressionKidney transplantationLiving donor transplantation

More Related Videos

Heterotopic Renal Autotransplantation in a Porcine Model: A Step-by-Step Protocol
11:47

Heterotopic Renal Autotransplantation in a Porcine Model: A Step-by-Step Protocol

Published on: February 21, 2016

12.0K
A Rat Orthotopic Renal Transplantation Model for Renal Allograft Rejection
06:59

A Rat Orthotopic Renal Transplantation Model for Renal Allograft Rejection

Published on: February 2, 2022

3.7K

Related Experiment Videos

Last Updated: May 1, 2026

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach
09:15

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach

Published on: May 7, 2019

15.8K
Heterotopic Renal Autotransplantation in a Porcine Model: A Step-by-Step Protocol
11:47

Heterotopic Renal Autotransplantation in a Porcine Model: A Step-by-Step Protocol

Published on: February 21, 2016

12.0K
A Rat Orthotopic Renal Transplantation Model for Renal Allograft Rejection
06:59

A Rat Orthotopic Renal Transplantation Model for Renal Allograft Rejection

Published on: February 2, 2022

3.7K

Area of Science:

  • Nephrology
  • Immunology
  • Transplantation

Background:

  • ABO incompatible kidney transplantation (ABOi-KT) was historically contraindicated due to hyperacute rejection risks.
  • Advances in immunosuppression and desensitization protocols have transformed ABOi-KT feasibility.
  • Increased donor pool and reduced waiting lists are key benefits of ABOi-KT.

Purpose of the Study:

  • To review the history, outcomes, protocols, and risks associated with ABOi-KT.
  • To evaluate the current status and future recommendations for ABOi-KT.
  • To compare the efficacy and safety of ABOi-KT with ABO compatible KT (ABOc-KT).

Main Methods:

  • Literature review of ABOi-KT history, outcomes, and protocols.
  • Analysis of desensitization and immunosuppression strategies in ABOi-KT.
  • Comparative assessment of ABOi-KT versus ABOc-KT outcomes and risks.

Main Results:

  • ABOi-KT outcomes are now comparable to ABOc-KT.
  • Current protocols involve intensified immunosuppression, increasing infection/malignancy risks and costs.
  • Protocol simplification has occurred over the last decade.

Conclusions:

  • ABOi-KT significantly expands donor options for end-stage kidney disease patients.
  • Despite residual risks and higher costs, ABOi-KT is a maturing therapeutic option.
  • Further research and protocol refinement are needed to optimize ABOi-KT's role.